APA

Nicholson S., Guile K., John J., Clarke I. A., Diffley J., Donnellan P., Michael A., Szlosarek P. & Dalgleish A. G. (20031125). A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanoma. : Melanoma research.

Chicago

Nicholson S, Guile K, John J, Clarke I A, Diffley J, Donnellan P, Michael A, Szlosarek P and Dalgleish A G. 20031125. A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanoma. : Melanoma research.

Harvard

Nicholson S., Guile K., John J., Clarke I. A., Diffley J., Donnellan P., Michael A., Szlosarek P. and Dalgleish A. G. (20031125). A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanoma. : Melanoma research.

MLA

Nicholson S, Guile K, John J, Clarke I A, Diffley J, Donnellan P, Michael A, Szlosarek P and Dalgleish A G. A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanoma. : Melanoma research. 20031125.